Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06893484 · ClinicalTrials.gov registry record
Assessment of Early Pregnancy MAB Completion
A clinical trial of Pregnancy and Abortion Early, sponsored by University of Washington.
- Recruiting
- Registry status
- 400
- Enrollment target
- 3
- Study locations
NCT06893484 is a study of Pregnancy and Abortion Early that is actively recruiting participants, run by University of Washington. The registered enrollment target is 400 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06893484, a study of Pregnancy and Abortion Early, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Weekly high-sensitivity urine pregnancy tests
Study Locations (3)
Georgia
- Carafem - Atlanta
Maryland
- Carafem - Chevy Chase
Washington
- Cedar River Clinics - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06893484
The ClinicalTrials.gov registry entry for NCT06893484 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Weekly high-sensitivity urine pregnancy tests is the first listed.
NCT06893484 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Maryland, Washington.
Frequently Asked Questions
What is clinical trial NCT06893484 about?
NCT06893484 is a clinical study titled "Assessment of Early Pregnancy MAB Completion". This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrol...
What is the current status of trial NCT06893484?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-03-13. Estimated completion is 2026-04.
What conditions does trial NCT06893484 study?
This clinical trial studies the following conditions: Pregnancy, Abortion Early.
What interventions are being tested in trial NCT06893484?
The interventions under investigation include: Weekly high-sensitivity urine pregnancy tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06893484?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06893484 being conducted?
This trial has 3 study locations across Georgia, Maryland, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.